Time to tackle clonorchiasis in China

Recent publication of the global epidemiology of clonorchiasis and its relationship with cholangiocarcinoma in the journal of Infectious Diseases of Poverty has stressed the importance of Clonorchis sinensis infection. To further demonstrate its threat on public health, especially in China, comparisons between clonorchiasis and hepatitis B are made in terms of epidemiology, clinical symptoms and carcinogenicity, disability, as well as changing trends. Furthermore, major problems and prioritized researches are argued, from basic biology to intervention. Imbalance between the majority of infected population and the minority of researches in China urges for more work from Chinese scientists and international cooperation.

[1]  M. W. Popejoy.  Book Review: What will work: Fighting Climate Change with Renewable Energy, Not Nuclear Power , 2012 .

[2]  M. Haswell-Elkins,et al.  Cross‐sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high‐risk area in northeast thailand , 1994, International journal of cancer.

[3]  J. Utzinger.  A Research and Development Agenda for the Control and Elimination of Human Helminthiases , 2012, PLoS neglected tropical diseases.

[4]  F. Lu,et al.  Management of hepatitis B in China. , 2009, Chinese medical journal.

[5]  D. Shouval.  Hepatitis B vaccines. , 2003, Journal of hepatology.

[6]  Guo-Jing Yang,et al.  A Research Agenda for Helminth Diseases of Humans: Modelling for Control and Elimination , 2012, PLoS neglected tropical diseases.

[7]  Shiyuan Liu,et al.  A meta-analysis of case–control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China , 2005, British Journal of Cancer.

[8]  Guo-Jing Yang,et al.  Spatial epidemiology in zoonotic parasitic diseases: insights gained at the 1st International Symposium on Geospatial Health in Lijiang, China, 2007 , 2009, Parasites & Vectors.

[9]  H. Sriplung,et al.  Epidemiology of liver cancer: an overview. , 2004, Asian Pacific journal of cancer prevention : APJCP.

[10]  Y. Li,et al.  Identification and analysis of tumour-associated antigens in hepatocellular carcinoma , 2005, British Journal of Cancer.

[11]  J. L. Sims.  Management of hepatitis. , 1969, Wisconsin medical journal.

[12]  Yu Wang,et al.  Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. , 2009, Vaccine.

[13]  S. Xiao,et al.  The in vitro and in vivo effect of tribendimidine and its metabolites against Clonorchis sinensis , 2009, Parasitology Research.

[14]  Chao Wu,et al.  Vaccination against hepatitis B: the Chinese experience. , 2009, Chinese medical journal.

[15]  Guo-Jing Yang,et al.  Disability Weight of Clonorchis sinensis Infection: Captured from Community Study and Model Simulation , 2011, PLoS neglected tropical diseases.

[16]  W. Fritz.  WHO‐IARC Monographs on the evaluation of carcinogenic risk of chemicals to humans. Supplement 2: Long‐Term and Short‐Term Screening Assays for carcinogens: A critical appraisal. 426 Seiten. International Agency for Research on Cancer, Lyon 1980. Preis: 40,‐sfrs.; 25,‐US$ , 1982 .

[17]  Sims Jl.  Management of hepatitis. , 1969, Wisconsin medical journal.

[18]  H. Carabin,et al.  Zoonoses and marginalised infectious diseases of poverty: Where do we stand? , 2011, Parasites & Vectors.

[19]  Guan-Tarn Huang,et al.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.

[20]  Guo-Jing Yang,et al.  A Research Agenda for Helminth Diseases of Humans: Social Ecology, Environmental Determinants, and Health Systems , 2012, PLoS neglected tropical diseases.

[21]  M. Tanner,et al.  Evaluation of the In Vivo Activity of Tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini , 2006, Antimicrobial Agents and Chemotherapy.

[22]  X. Cai,et al.  Genetic variation among Clonorchis sinensis isolates from different geographic regions in China revealed by sequence analyses of four mitochondrial genes , 2011, Journal of Helminthology.

[23]  Jennifer Keiser,et al.  Food-Borne Trematodiases , 2009, Clinical Microbiology Reviews.

[24]  S. Liang,et al.  The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. , 2012, Parasitology international.

[25]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[26]  Guo-Jing Yang,et al.  A Research Agenda for Helminth Diseases of Humans: Intervention for Control and Elimination , 2012, PLoS neglected tropical diseases.

[27]  J. Utzinger,et al.  Efficacy and safety of tribendimidine against Clonorchis sinensis. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Guo-Jing Yang,et al.  A Research Agenda for Helminth Diseases of Humans: Diagnostics for Control and Elimination Programmes , 2012, PLoS neglected tropical diseases.

[29]  Margaret Chan,et al.  Working to overcome the global impact of neglected tropical diseases : first WHO report on neglected tropical diseases , 2010 .

[30]  Song Liang,et al.  The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma , 2012, Infectious Diseases of Poverty.

[31]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[32]  T. Wilkins,et al.  Hepatitis B: diagnosis and treatment. , 2010, American family physician.